Incyte Corp | INCY - Cost Of Sales

Name: Incyte Corp | INCY - Cost Of Sales
Creator: TRADING ECONOMICS
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Incyte,Corp,INCY,Cost,Of,Sales,stock,equity,live,intraday,earnings,share,price,historical data,chart,calendar,dividend,yield,news

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

Features Questions? Contact us Already a Member? Login

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us

Please Paste this Code in your Website

width

height

Preview

Incyte Corp

Incyte Corp reported $51.42M in Cost of Sales for its fiscal quarter ending in March of 2023.

	Cost Of Sales		Date
Acadia Pharmaceuticals ACAD:US	USD 1.67M	746K	Mar/2023
Agenus AGEN:US	USD 2.29M	5.4M	Mar/2023
Agios Pharmaceuticals AGIO:US	USD 554K	141K	Mar/2023
Alnylam Pharmaceuticals ALNY:US	USD 54.87M	3.6M	Mar/2023
Amgen AMGN:US	USD 1.68B	65M	Mar/2023
BioCryst Pharmaceuticals BCRX:US	USD 938K	1.56M	Mar/2023
Biogen BIIB:US	USD 662.8M	91.9M	Mar/2023
BioMarin Pharmaceutical BMRN:US	USD 126.55M	741K	Mar/2023
Bluebird Bio BLUE:US	USD 3.38M	3.36M	Mar/2023
Bristol-Myers Squibb BMY:US	USD 2.56B	45M	Mar/2023
CTI Biopharma CTIC:US	USD 1.22M	57K	Mar/2023
Eli Lilly LLY:US	USD 1.63B	78.6M	Mar/2023
Exelixis EXEL:US	USD 14.32M	1.6M	Mar/2023
Gilead Sciences GILD:US	USD 1.4B	5M	Mar/2023
Incyte Corp INCY:US	USD 51.42M	2.34M	Mar/2023
Intercept Pharmaceuticals ICPT:US	USD 222K	194K	Mar/2023
Ionis Pharmaceuticals IONS:US	USD 1.34M	2.34M	Mar/2023
MacroGenics MGNX:US	USD 3.52M	1.73M	Mar/2023
Merck & Co MRK:US	USD 3.35B	491M	Mar/2023
Mirati Therapeutics MRTX:US	USD 817K	217K	Mar/2023
Moderna Inc MRNA:US	USD 792M	1.13B	Mar/2023
Nektar Therapeutics NKTR:US	USD 7.06M	827K	Mar/2023
Neurocrine Biosciences NBIX:US	USD 8.5M	800K	Mar/2023
Novartis NOVN:VX	USD 3.83B	8M	Mar/2023
Novartis NVS:US	USD 3.83B	8M	Mar/2023
Pfizer PFE:US	USD 5.03B	4.8B	Mar/2023
PTC Therapeutics PTCT:US	USD 14.14M	3.25M	Mar/2023
Puma Biotechnology PBYI:US	USD 13.22M	3.62M	Mar/2023
Regeneron Pharmaceuticals REGN:US	USD 457.5M	83.1M	Mar/2023
Sarepta Therapeutics SRPT:US	USD 35.02M	4.22M	Mar/2023
Seattle Genetics SGEN:US	USD 111.78M	3.57M	Mar/2023
Ultragenyx Pharmaceutical RARE:US	USD 12.26M	6.94M	Mar/2023
Vertex Pharmaceuticals VRTX:US	USD 266.9M	16.4M	Mar/2023